Morgan Stanley
MS
$217.36
-0.47%
Morgan Stanley is a global financial services firm providing investment banking, wealth management, and asset management services across 42 countries, with over 83,000 employees. It is a market leader in wealth and asset management, boasting $9.3 trillion in client assets, and maintains a top-tier institutional securities franchise. The current investor narrative centers on the firm's successful pivot toward stable fee-based businesses, driving record revenue and earnings growth, while also navigating a dynamic capital markets environment and potential regulatory shifts. Recent attention has been fueled by strong quarterly results, a rebound in investment banking fees, and the firm's ability to generate robust returns on equity.…
MS
Morgan Stanley
$217.36
Related headlines
Investment Opinion: Should I buy MS Today?
Based on the analysis, Morgan Stanley is rated a Buy. The thesis is that the firm's strong revenue growth, improving margins, and attractive valuation (PEG 0.60) provide a favorable risk/reward, with an average analyst target of $236.62 implying 9.4% upside. The consensus recommendation is Buy, supported by 21 analysts.
Sign up to view all
MS 12-Month Price Forecast
The AI model assesses Morgan Stanley as a bullish opportunity, driven by strong revenue growth and attractive valuation. However, confidence is medium due to high leverage and negative free cash flow. The stance would be upgraded if free cash flow turns positive and revenue growth accelerates, or downgraded if market conditions deteriorate significantly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Morgan Stanley's 12-month outlook, with a consensus price target around $236.62 and implied upside of +8.9% versus the current price.
Average Target
$236.62
0 analysts
Implied Upside
+8.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$184 - $262
Analyst target range
The target price range spans from a low of $184.00 to a high of $262.00, reflecting a wide dispersion of expectations. The high target suggests potential for continued outperformance, possibly driven by sustained strength in wealth management and investment banking, while the low target may factor in risks such as market volatility or regulatory changes. Recent ratings actions have been mixed, with UBS and B of A maintaining Buy ratings, while Oppenheimer downgraded to Underperform, indicating some divergence in analyst views. The wide range highlights uncertainty about the sustainability of current earnings levels, but the overall consensus remains positive.
Bulls vs Bears: MS Investment Factors
Morgan Stanley presents a compelling growth story with accelerating revenue, improving margins, and a PEG ratio below 1, indicating undervaluation. However, high leverage, negative free cash flow, and proximity to 52-week highs introduce risks. The bull case currently has stronger evidence, driven by robust earnings growth and diversified revenue, but the key tension is whether the market's optimism is justified given the stock's rich valuation and potential for a pullback. The outcome hinges on sustained capital markets activity and the ability to convert earnings into positive free cash flow.
Bullish
- Strong Revenue Growth: Q2 2026 revenue surged 22.4% YoY to $34.47B, with sequential growth from $33.15B in Q1, indicating accelerating momentum across wealth management and institutional securities.
- Attractive Valuation with PEG of 0.60: With a forward PE of 15.87x and expected EPS growth of ~8%, the PEG ratio of 0.60 suggests the stock is undervalued relative to its growth, offering a margin of safety.
- Robust Profitability Metrics: Operating margin improved to 21.5% in Q2 2026, up from 16.4% in Q2 2025, while net margin expanded to 16.2%, reflecting strong operational leverage.
- Diversified Business Model: Revenue streams are well-balanced: wealth management contributed $8.43B, institutional securities $7.93B, and investment management $1.72B in Q2, reducing reliance on any single segment.
Bearish
- High Debt-to-Equity Ratio: Debt-to-equity stands at 4.26x, reflecting significant leverage typical of banks but amplifying vulnerability to credit market stress or rising rates.
- Negative Free Cash Flow: TTM free cash flow is -$1.05B, indicating cash outflows exceed inflows, which could constrain capital returns or force reliance on external funding.
- Trading Near 52-Week High: At $216.33, the stock is 93% of its 52-week range (high $232.25), leaving limited room for upside if sentiment shifts, with a max drawdown of -19.28% in the past year.
- Mixed Analyst Sentiment: While consensus is Buy, Oppenheimer downgraded to Underperform, and a recent article warns bank stocks are 'priced for perfection' ahead of Q2 earnings, signaling potential for downgrades.
MS Technical Analysis
Morgan Stanley's stock is in a strong uptrend, with a 1-year price change of +53.5%, significantly outperforming the S&P 500's +22.3% gain. The current price of $216.33 sits at 93% of its 52-week range (low: $141.03, high: $232.25), indicating the stock is trading near its highs, reflecting robust momentum and investor confidence. This positioning suggests the market is rewarding the firm's earnings growth, though it also raises the risk of short-term overextension.
Beta
1.21
1.21x market volatility
Max Drawdown
-19.3%
Largest decline past year
52-Week Range
$141-$232
Price range past year
Annual Return
+46.4%
Cumulative gain past year
| Period | MS Return | S&P 500 |
|---|---|---|
| 1m | -4.9% | +2.9% |
| 3m | +12.9% | +5.0% |
| 6m | +27.0% | +13.9% |
| 1y | +46.4% | +20.4% |
| ytd | +19.5% | +13.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MS Fundamental Analysis
Morgan Stanley's revenue trajectory is accelerating, with Q2 2026 revenue of $34.47 billion, up 22.4% year-over-year, and sequential growth from $33.15 billion in Q1 2026. The firm's wealth management segment contributed $8.43 billion in revenue, while institutional securities generated $7.93 billion, and investment management added $1.72 billion, showing diversified growth across business lines. This robust growth is driven by strong client activity in trading and investment banking, as well as continued asset gathering in wealth management.
Quarterly Revenue
$34.5B
2026-06
Revenue YoY Growth
+22.4%
YoY Comparison
Gross Margin
61.7%
Latest Quarter
Free Cash Flow
$-1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MS Overvalued?
Given Morgan Stanley's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 17.17x, while the forward PE is 15.87x, indicating the market expects earnings growth of approximately 8% over the next year. The PEG ratio of 0.60 suggests the stock is undervalued relative to its growth rate, as a PEG below 1 typically indicates a potential bargain. This gap between trailing and forward multiples implies that analysts expect continued earnings expansion, driven by strong capital markets activity and operational leverage.
PE
17.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a high debt-to-equity ratio of 4.26x, which amplifies exposure to interest rate hikes and credit market disruptions. Negative free cash flow of -$1.05B TTM indicates the firm is not generating sufficient cash to cover investments and dividends, potentially leading to increased borrowing or reduced capital returns. Revenue concentration in capital markets activities, which are cyclical, could cause earnings volatility, as seen in the 22.4% YoY growth that may not be sustainable if market conditions deteriorate.